Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis.
about
Hemophagocytic syndromes and infectionHuman herpesvirus 6Does immune serum globulin confer protection against skin diseases?Human herpesvirus-6 (HHV-6)-associated hemophagocytic syndrome.Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH).Very high serum ferritin levels in three newborns with Kawasaki-like illness.Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy.Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.Epstein-barr virus-related hemophagocytic lymphohistiocytosis: hematologic emergency in the critical care setting.Clinical features and correct diagnosis of macrophage activation syndrome.Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.The use of cyclosporin-A in the treatment of virus-associated hemophagocytic syndrome in adults.Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.Therapeutic approaches for severe Epstein-Barr virus infection.Lymphoproliferative Syndromes Associated with Human Herpesvirus-6A and Human Herpesvirus-6B.
P2860
Q24653852-98A34E4B-4EF2-454A-85D4-67DE949C8382Q24683663-E5283047-4E44-4027-AA85-D3A5627A0C3FQ30917379-2ABDD842-E147-44E2-8267-42271A9E2ACCQ33970258-EBE3FB43-A8A9-4CFB-9FF9-032FFF61B095Q34024242-F7A317C7-8BBB-48AF-9A6A-3F1BC26EC4B2Q36054020-D2142BFD-FDFB-476A-81A0-A372B4720609Q37373485-D9C7B579-3EBB-4B5F-83D6-E6C53D4DACF5Q37618900-A82D340F-F68B-440D-B5F6-02D05C2C3192Q37729056-786C925F-3E25-4E7E-893C-BBB533FE5CB5Q37993678-E59AC939-9BB0-4B42-9194-8710010F3924Q38371707-01786379-3842-465E-961B-7B8DBFB3AC33Q38530013-957839E8-E96A-4A59-B003-FB23AB0E7170Q40207981-0140DE50-8AE4-46A8-B79B-8ADE61E6990EQ40598920-1F1134E0-B838-423D-A8C9-189FB4A157A3Q40641188-07FC3E8D-88FD-4CFA-AD81-B5215FC3A4CAQ40877030-F81219D9-B5DB-467D-B9D2-5B7B31D6879FQ41412514-94A72B27-A088-4E52-BDBE-384657ED137BQ54213118-FCDD2293-AB0A-4B4D-BC27-D1132FA2CCC9
P2860
Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@ast
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@en
type
label
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@ast
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@en
prefLabel
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@ast
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@en
P2093
P2860
P1476
Immunomodulation treatment for ...... hagocytic lymphohistiocytosis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1995.TB03302.X
P407
P577
1995-02-01T00:00:00Z